Miguel
Alcoceba Sánchez
Investigador desde 2011
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (8)
2023
-
Unraveling the genetics of transformed splenic marginal zone lymphoma
Blood Advances, Vol. 7, Núm. 14, pp. 3695-3709
2022
-
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression
Blood Advances, Vol. 6, Núm. 21, pp. 5763-5773
-
Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation
British Journal of Haematology, Vol. 196, Núm. 1, pp. 146-155
-
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
Nature Medicine, Vol. 28, Núm. 8, pp. 1662-1671
-
Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications
Histopathology, Vol. 81, Núm. 6, pp. 826-840
2021
-
Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative
Annals of Hematology, Vol. 100, Núm. 3, pp. 825-830
2017
-
Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome
Hematological Oncology, Vol. 35, Núm. 4, pp. 520-527
2015
-
CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival
Journal of Pathology, Vol. 235, Núm. 3, pp. 445-455